Literature DB >> 9740397

Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain.

L Giovannelli1, C Scali, M S Faussone-Pellegrini, G Pepeu, F Casamenti.   

Abstract

The long-term effects of beta-amyloid peptide 1-40 injection into the rat forebrain were studied. Ten micrograms of pre-aggregated peptide were injected into the right nucleus basalis of male Wistar rats which were then killed four or six months later. Congo Red staining of histological sections showed that the peptide deposit was aggregated in a fibrillary form four months post-surgery, whereas at six months almost no trace of birefringency was detected at the deposit site, indicating a loss of fibril organization. This result was confirmed by electron microscopic analysis of the peptide deposits. The presence of the peptide at the injection site six months post-surgery was demonstrated by both Haematoxylin staining and beta-amyloid immunoreactivity. The number of choline acetyltransferase-immunoreactive neurons was reduced by 66% in the injected nucleus basalis four months after injection. A decrease in cortical acetylcholine release was also found at this time. Concomitantly with the loss of fibril conformation, a complete recovery of choline acetyltransferase immunoreactivity in the nucleus basalis and of acetylcholine release in the cortex was observed at six months. These data provide in vivo evidence that beta-amyloid neurotoxicity is related to the fibrillary conformation of the peptide aggregates, thus confirming previous in vitro studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740397     DOI: 10.1016/s0306-4522(98)00169-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Repeated rapid shear-responsiveness of peptide hydrogels with tunable shear modulus.

Authors:  Sivakumar Ramachandran; Yiider Tseng; Y Bruce Yu
Journal:  Biomacromolecules       Date:  2005 May-Jun       Impact factor: 6.988

2.  Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.

Authors:  Jennifer Horgan; Jose Javier Miguel-Hidalgo; Martha Thrasher; Garth Bissette
Journal:  J Alzheimers Dis       Date:  2007-09       Impact factor: 4.472

3.  The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.

Authors:  J Meunier; J Ieni; T Maurice
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

4.  Huperzine A reverses cholinergic and monoaminergic dysfunction induced by bilateral nucleus basalis magnocellularis injection of beta-amyloid peptide (1-40) in rats.

Authors:  Yan Qi Liang; Xiao Tian Huang; Xi Can Tang
Journal:  Cell Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.046

5.  The effect of beta-amyloid on neurons and the influence of glucocorticoid and age on such effect.

Authors:  Honghui Chen; Shenggang Sun; Yuanwu Mei; Changqin Liu; Anqiu Liu; Etang Tong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 6.  Intracellular A-beta amyloid, a sign for worse things to come?

Authors:  Valentina Echeverria; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

7.  Evolution of beta-amyloid induced neuropathology: magnetic resonance imaging and anatomical comparisons in the rodent hippocampus.

Authors:  Yusuf A Bhagat; André Obenaus; J Steven Richardson; Edward J Kendall
Journal:  MAGMA       Date:  2002-06       Impact factor: 2.533

8.  Global analysis of ginsenoside Rg1 protective effects in β-amyloid-treated neuronal cells.

Authors:  Ji Seon Shim; Min-Young Song; Sung-Vin Yim; Seung-Eun Lee; Kang-Sik Park
Journal:  J Ginseng Res       Date:  2016-12-08       Impact factor: 6.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.